Recently selected Food and Drug Administration chief lawyer, Hilary K. Perkins, has resigned from the job, according to a ...

Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.

In the Boston area, three months into the new year, the mood in the biotech industry has soured and the outlook has clouded.

Michael Lewis on Heather Stone of the Food and Drug Administration.

Zaarah Herbals’ Rasayan Churan, Gurmar Powder, Vasaka Powder, and Bhringraj Powder recalled in four states due to potential ...

Four powdered supplements from Zaarah Herbals were recently recalled by their manufacturer due to potential “elevated levels of lead and arsenic,” the U.S. Food and Drug Administration (FDA) announced ...

There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.

FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...

Health and Human Services Secretary Robert F. Kennedy Jr. took aim at a long-criticized food safety loophole on March 10, ...

US Health and Human Services secretary Robert F. Kennedy Jr. directs the Food and Drug Administration to explore revamping ...

The nation's top health official, Robert F. Kennedy Jr., is taking steps to tighten oversight of chemicals in the U.S. food ...

The California Department of Public Health notified the FDA about “multiple illnesses” related to consumers eating Frozen ...